0.5700
-0.0100
(-1.72%)
At close: January 10 at 2:08:32 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Patrice P. Rioux M.D., Ph.D. | Co-Founder, CEO & Director | 261.68k | -- | 1951 |
| Mr. Brook G. Riggins C.F.A. | CFO, Secretary & Director | 221.78k | -- | 1966 |
| Ms. Mary Jo Bagger | Consultant for Clinical Operations | -- | -- | -- |
Thiogenesis Therapeutics, Corp.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Thiogenesis Therapeutics, Corp., a biopharmaceutical company, develops thiol-active therapeutic compounds to treat unmet pediatric medical needs. The company's lead product candidate comprises TTI-0102, a prodrug that consists of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke, other mitochondrial diseases, Rett syndrome, and pediatric non-alcoholic fatty liver diseases. Thiogenesis Therapeutics, Corp. is headquartered in Toronto, Canada.
Corporate Governance
Thiogenesis Therapeutics, Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 19, 2024 at 10:59 AM UTC
Thiogenesis Therapeutics, Corp. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
NWRN.SW Newron Pharmaceuticals S.p.A.
8.88
+1.72%
SANN.SW Santhera Pharmaceuticals Holding AG
13.68
-2.84%
RLF.SW Relief Therapeutics Holding SA
3.8500
-1.53%
RKV.V Rakovina Therapeutics Inc.
0.1750
-2.78%
IDIA.SW Idorsia Ltd
0.7790
-1.77%
GBIO Generation Bio Co.
0.9255
+1.69%
BOLT Bolt Biotherapeutics, Inc.
0.5387
-4.69%
SVA.TO Sernova Corp.
0.2250
0.00%
NCNA NuCana plc
1.1300
-1.74%
PBM Psyence Biomedical Ltd.
1.7000
-7.61%